NCT01601522View on ClinicalTrials.gov

Peanut Allergy Oral Immunotherapy Desensitization

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Peanut Allergy
Interventions
PROCEDURE

Peanut protein

500 mg

PROCEDURE

Oat flour

500 mg Oat flour

DRUG

Antihistamine

Desloratidine 5 ml po od (0.5mg/ml = 2.5 mg) Ranitidine 5ml (15mg/ml=75 mg) po bid

Trial Locations (1)

L8N 3Z5

McMaster University, Hamilton

All Listed Sponsors
collaborator

AllerGen NCE Inc.

INDUSTRY

collaborator

McMaster University

OTHER

lead

Hamilton Health Sciences Corporation

OTHER

NCT01601522 - Peanut Allergy Oral Immunotherapy Desensitization | Biotech Hunter | Biotech Hunter